%0 Generic %A P., Soltanzadeh %A S., Nafissi %A A., Ghorbani %A H., Sikaroodi %A J., Lotfi %A A., Soltanzadeh %D 2006 %T Supplementary Material for: Wilson’s Disease: A Great Masquerader %U https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Wilson_s_Disease_A_Great_Masquerader/5104549 %R 10.6084/m9.figshare.5104549.v1 %2 https://karger.figshare.com/ndownloader/files/8663824 %2 https://karger.figshare.com/ndownloader/files/8663827 %2 https://karger.figshare.com/ndownloader/files/8663830 %2 https://karger.figshare.com/ndownloader/files/8663833 %2 https://karger.figshare.com/ndownloader/files/8663836 %K Wilson’s disease %K Hepatolenticular degeneration %K Movement disorders %K Iran %X Background: Wilson’s disease (WD) is a treatable autosomal recessive metabolic disorder which could lead to protean hepatic or neurologic manifestations. WD could mimic many neurologic disorders and is often diagnosed with a long delay. This study describes central nervous system manifestations of a group of Iranian patients with neurologic WD. Methods: Data from case records of patients with neurologic WD presenting at a referral university hospital and a private clinic in Tehran from 1984 to 2004 were analyzed. Results: Fifty patients from 44 unrelated families with WD were identified, whose mean duration of follow-up was 51.8 (±58.5) months. The median age of onset of neurologic symptoms in 37 patients with primary neurologic or simultaneous hepatic-neurologic presentation was 16 (10–38) years, whereas in 13 patients with prior hepatic damage, this was 18.5 (11–34) years. The 6 most common manifestations were dysarthria (80%), drooling (48%), tremor in limbs (44%), abnormal gait (44%), psychiatric and/or sleep symptoms (44%), and dystonia in limbs (42%). Conclusion: Neurologic WD has heterogeneous manifestations and should be considered in young patients presenting with dysarthria, drooling, any kind of movement disorders or psychiatric symptoms. %I Karger Publishers